IkT-001Pro, Placebo to match 100 mg IKT-001 tablets clinical trials

An Adaptive, 2-Part, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of IKT-001 in Pulmonary Arterial Hypertension.

This study is looking into a new tablet medicine, IKT-001, for a serious lung condition called pulmonary arterial hypertension. It aims to see if the medicine is safe and helps people walk further and feel better.